Legend Biotech (LEGN) Tax Provisions (2019 - 2026)
Legend Biotech's (LEGN) quarterly Tax Provisions came in at $1.2 million in Q1 2026, down 33.33% YoY from $1.8 million in Q1 2025, and up 294.81% on a QoQ basis from -$616000.0 in Q3 2025.
Legend Biotech (LEGN) Tax Provisions (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Tax Provisions data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Tax Provisions fell 33.33% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 91.3% YoY) and the FY2024 annual result came in at $18.9 million, up 1094.74% from the prior year.
- Tax Provisions grew to $1.2 million in Q1 2026, from -$616000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $23.6 million in Q4 2024 to a low of -$4.4 million in Q3 2024.
- A 5-year average of $1.2 million and a median of -$142500.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 4093.14% — and 2025, when it soared 36100.0%.
- Tracing LEGN's Tax Provisions over 5 years: stood at $125000.0 in 2022, then sank by 1516.0% to -$1.8 million in 2023, then surged by 1431.41% to $23.6 million in 2024, then slumped by 102.61% to -$616000.0 in 2025, then surged by 294.81% to $1.2 million in 2026.
- The last three Tax Provisions figures came in at $1.2 million (Q1 2026), -$616000.0 (Q3 2025), and -$582000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 22.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.30 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Sep 30, 2025 | -616,000.00 |
| Jun 30, 2025 | -582,000.00 |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 23.57 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -1.77 Mn |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | -290,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Dec 31, 2022 | 125,000.00 |
| Sep 30, 2022 | 820,000.00 |
| Jun 30, 2022 | -157,000.00 |
| Mar 31, 2022 | -163,000.00 |
| Dec 31, 2021 | -3.61 Mn |
| Jun 30, 2021 | -5,082.00 |
| Mar 31, 2021 | 4,082.00 |